Literature DB >> 12783318

Melatonin for treatment of sleeping disorders in children with attention deficit/hyperactivity disorder: a preliminary open label study.

Cecil V Tjon Pian Gi1, Joris P A Broeren2, J Sander Starreveld2, Florens G A Versteegh2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12783318     DOI: 10.1007/s00431-003-1207-x

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


× No keyword cloud information.
  6 in total

1.  Side effects of methylphenidate and dexamphetamine in children with attention deficit hyperactivity disorder: a double-blind, crossover trial.

Authors:  D Efron; F Jarman; M Barker
Journal:  Pediatrics       Date:  1997-10       Impact factor: 7.124

2.  Pro-convulsant effects of oral melatonin in neurologically disabled children.

Authors:  S H Sheldon
Journal:  Lancet       Date:  1998-04-25       Impact factor: 79.321

Review 3.  Management of stimulant medications in children with attention-deficit/hyperactivity disorder.

Authors:  A R Adesman; A M Morgan
Journal:  Pediatr Clin North Am       Date:  1999-10       Impact factor: 3.278

Review 4.  Melatonin: a sleep-promoting hormone.

Authors:  I V Zhdanova; H J Lynch; R J Wurtman
Journal:  Sleep       Date:  1997-10       Impact factor: 5.849

Review 5.  Use of melatonin in the treatment of paediatric sleep disorders.

Authors:  J E Jan; M E O'Donnell
Journal:  J Pineal Res       Date:  1996-11       Impact factor: 13.007

Review 6.  Melatonin: therapeutic use in sleep disorders.

Authors:  J E Chase; B E Gidal
Journal:  Ann Pharmacother       Date:  1997-10       Impact factor: 3.154

  6 in total
  13 in total

Review 1.  Sleep in Infants and Children with Prenatal Alcohol Exposure.

Authors:  Sarah M Inkelis; Jennifer D Thomas
Journal:  Alcohol Clin Exp Res       Date:  2018-05-31       Impact factor: 3.455

Review 2.  Managing the risks of ADHD treatments.

Authors:  Benjamin N Schneider; Michael Enenbach
Journal:  Curr Psychiatry Rep       Date:  2014-10       Impact factor: 5.285

3.  Therapeutics for Circadian Rhythm Sleep Disorders.

Authors:  Ehren R Dodson; Phyllis C Zee
Journal:  Sleep Med Clin       Date:  2010-12

Review 4.  Safety, Tolerability and Efficacy of Drugs for Treating Behavioural Insomnia in Children with Attention-Deficit/Hyperactivity Disorder: A Systematic Review with Methodological Quality Assessment.

Authors:  Shweta Anand; Henry Tong; Frank M C Besag; Esther W Chan; Samuele Cortese; Ian C K Wong
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

Review 5.  The Role of the Circadian System in Attention Deficit Hyperactivity Disorder.

Authors:  Upasana Bondopadhyay; Unai Diaz-Orueta; Andrew N Coogan
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 6.  Attention deficit hyperactivity disorder, tics and Tourette's syndrome: the relationship and treatment implications. A commentary.

Authors:  Mary M Robertson
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-02       Impact factor: 4.785

7.  Abnormal melatonin synthesis in autism spectrum disorders.

Authors:  J Melke; H Goubran Botros; P Chaste; C Betancur; G Nygren; H Anckarsäter; M Rastam; O Ståhlberg; I C Gillberg; R Delorme; N Chabane; M-C Mouren-Simeoni; F Fauchereau; C M Durand; F Chevalier; X Drouot; C Collet; J-M Launay; M Leboyer; C Gillberg; T Bourgeron
Journal:  Mol Psychiatry       Date:  2007-05-15       Impact factor: 15.992

8.  Study protocol: the sleeping sound with attention-deficit/hyperactivity disorder project.

Authors:  Emma Sciberras; Daryl Efron; Bibi Gerner; Margot Davey; Fiona Mensah; Frank Oberklaid; Harriet Hiscock
Journal:  BMC Pediatr       Date:  2010-12-30       Impact factor: 2.125

9.  Drug therapy of attention deficit hyperactivity disorder: current trends.

Authors:  Avinash De Sousa; Gurvinder Kalra
Journal:  Mens Sana Monogr       Date:  2012-01

Review 10.  Associations of sleep disturbance with ADHD: implications for treatment.

Authors:  Allan Hvolby
Journal:  Atten Defic Hyperact Disord       Date:  2014-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.